by The global Orthopedic Regenerative Surgical Products market size was valued at US$ 5.4 billion in 2020 and is anticipated to grow at a CAGR of 8.6% during forecast period 2021 to 2030.
Orthopedic Regenerative Surgical Products Market (By Product: Allograft, Synthetic, Cell-based, Viscosupplements; By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction, Others; By End-user: Hospitals, Ambulatory Surgical Centers, Others (Orthopedic Specialty Centers, Clinics)) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38318
Growth Factors
The key factors driving the market growth include the rising geriatric population, orthopedic procedures, research activities, and technological advancements. Osteoarthritis, for instance, has been identified as the leading cause of chronic disability in the geriatric population over the age of 70. The World Health Organization (WHO) has also designated osteoarthritis as a ‘priority disease’ promoting R&D for therapies to treat osteoarthritis and its associated symptoms.
The growth of the market was restrained during the COVID-19 pandemic due to deferred elective surgeries, low volume of patient flow for chronic conditions in clinics and hospitals, decreased sales and marketing activities, quarantine and lockdown protocols, and low demand. Vericel Corporation, for example, reported the adverse impact of COVID-19 on its business and operations during 2020. The company registered cancellations of scheduled MACI procedures; its key product used in the repair of cartilage damage of the knee. In addition, there was a slowdown in new orders. Anika Therapeutics reported challenges in patient enrollment for its due to the pandemic, which negatively impacted on the company’s revenue and operating results. However, both companies expect recovery financial performance as elective surgeries resume to pre-COVID numbers.
| Report Coverage | Details |
| Market Size | US$ 10.2 billion by 2030 |
| Growth Rate | CAGR of 8.6% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Application, End-user |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Key Players
- Anika Therapeutics, Inc.
- Vericel Corporation
- Baxter
- Zimmer Biomet
- Stryker
- Smith+Nephew
- AlloSource
- Amniox Medical, Inc.
- VSY Biotechnology
- Aptissen S.A
- MiMedx
Market Segmentation
- Product Outlook
- Allograft
- Amniotic Products
- Others
- Synthetic
- Cell-based
- Viscosupplements
- Allograft
- Application Outlook
- Orthopedic Pain Management
- Trauma Repair
- Cartilage and Tendon Repair
- Joint Reconstruction
- Others
- End-user Outlook
- Hospitals
- Ambulatory Surgical Centers
- Others (Orthopedic Specialty Centers, Clinics)
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38318
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Application Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Regenerative Surgical Products Market, By Product
7.1. Orthopedic Regenerative Surgical Products Market, by Product, 2021-2030
7.1.1. Allograft
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Synthetic
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Cell-based
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Viscosupplements
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Orthopedic Regenerative Surgical Products Market, By Application
8.1. Orthopedic Regenerative Surgical Products Market, by Application, 2021-2030
8.1.1. Orthopedic Pain Management
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Trauma Repair
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Cartilage and Tendon Repair
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Joint Reconstruction
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Orthopedic Regenerative Surgical Products Market, By End User
9.1. Orthopedic Regenerative Surgical Products Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Others (Orthopedic Specialty Centers, Clinics)
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Orthopedic Regenerative Surgical Products Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2030)
Chapter 11. Company Profiles
11.1. Vericel Corporation
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Baxter
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Zimmer Biomet
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Stryker
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Smith+Nephew
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. AlloSource
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Amniox Medical, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. VSY Biotechnology
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Aptissen S.A
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. MiMedx
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38318
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
